Achilles Therapeutics News

Achilles Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 24 06:01

Achilles Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 17 16:19

Achilles Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

May 8 06:48

Achilles Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Apr 4 07:30

Achilles Therapeutics | 20-F: Registration statement / Annual report / Transition report

Apr 4 07:15

Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(1.9%),Invus Public Equities Advisors, LLC(1.9%), etc.

Mar 29 15:33

Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(8.1%),Baker Bros. Advisors (GP) LLC(8.1%), etc.

Feb 14 16:49

Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Feb 13 17:46

Achilles Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 1 12:17

Achilles Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 13, 2023 15:36

Achilles Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 1, 2023 16:26

Achilles Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 22, 2023 15:42

Achilles Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 17, 2023 14:16

Achilles Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 4, 2023 06:42

Achilles Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jun 29, 2023 15:03

Achilles Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

May 10, 2023 07:46

Achilles Therapeutics | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Apr 24, 2023 16:02

Achilles Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 8, 2023 07:04

Achilles Therapeutics: FY2022 Annual Report

20-F | Achilles Therapeutics plc (0001830749) (Filer)

Mar 7, 2023 15:37

Achilles Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(3.9%),Jeremy C. Green(3.9%)

Feb 14, 2023 15:29